Optik Research Updates image presented by CRO

Myopia Control: Ortho-K vs. Low-Dose Atropine

Based on: JAMA Ophthalmology, 2025 – Randomized Clinical Trial At a Glance Population: Children & adolescents with progressing...

Read More
East optical MyoPro

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

Newly published two-year clinical data in Investigative Ophthalmology & Visual Science (IOVS) confirm that the MyoPro® Defocus Lens continues...

Read More
EssilorLuxottica

EssilorLuxottica Invests $1.5M CAD in Canada’s Optometry Schools to Fuel Research and Train the Next Generation of Eye Care Leaders

EssilorLuxottica announced a multi-year pledge of more than $15M CAD to The Université de Montréal – École d’Optométrie and the University...

Read More
Optik TECH Septembre-Octobre 2025 Centennial Optical- Rodenstock MyCon™2

Rodenstock MyCon™2: A New Geneation of Children’s Lenses Created to Control Myopia

With MyCon™ 2, Rodenstock takes four individual wearing parameters into account when calculating the lens (PD, CVD, PT & FFA) This provides a...

Read More
SightGlass Vision

Academy ’25: New Data Strengthens Evidence for DOT™ Myopia Control Lenses

SightGlass Vision presented new data at the American Academy of Optometry 2025 Annual Meeting in Boston showing the continued effectiveness of its...

Read More
1 2 3 4